Pilot Study on the Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis.
Phase of Trial: Phase IV
Latest Information Update: 30 Nov 2012
At a glance
- Drugs Adalimumab (Primary) ; Antipsoriatics
- Indications Plaque psoriasis
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 01 Aug 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 01 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History